Yatin Suneja
Stock Analyst at Guggenheim
(4.65)
# 212
Out of 5,182 analysts
168
Total ratings
57.52%
Success rate
24.95%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics | Maintains: Buy | $60 → $125 | $60.60 | +106.27% | 3 | Apr 6, 2026 | |
| NMRA Neumora Therapeutics | Reiterates: Buy | $14 | $2.13 | +557.28% | 4 | Mar 31, 2026 | |
| DBVT DBV Technologies | Reiterates: Buy | $51 | $20.45 | +149.39% | 3 | Mar 27, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $220 → $245 | $168.74 | +45.19% | 11 | Mar 25, 2026 | |
| CABA Cabaletta Bio | Maintains: Buy | $15 → $16 | $3.07 | +421.17% | 7 | Mar 24, 2026 | |
| IMUX Immunic | Initiates: Buy | $7 | $1.19 | +488.24% | 1 | Mar 24, 2026 | |
| IFRX InflaRx | Maintains: Buy | $22 → $14 | $0.97 | +1,347.48% | 7 | Mar 20, 2026 | |
| ZBIO Zenas BioPharma | Maintains: Buy | $45 → $55 | $22.48 | +144.66% | 4 | Mar 17, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $128 → $100 | $6.43 | +1,455.21% | 4 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $100 → $200 | $86.20 | +132.02% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $36.76 | +36.02% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $25 | $11.55 | +116.45% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,160 → $1,120 | $765.43 | +46.32% | 14 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $760 → $800 | $306.69 | +160.85% | 5 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $865 → $975 | $760.27 | +28.24% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $246 | $175.61 | +40.08% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $27.75 | +8.11% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $24.61 | +78.79% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $15.92 | +214.07% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $32 | $22.31 | +43.43% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.76 | +298.94% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $62.13 | +60.95% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $116.48 | +28.78% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $17.08 | +17.10% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $26.17 | +186.59% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $130.90 | +33.69% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $5.04 | +415.87% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $14.68 | +97.55% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.65 | +165.49% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $25.77 | +74.62% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $22.09 | -9.46% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.90 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $51.20 | +26.95% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $31.35 | +187.08% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.09 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $57.65 | -15.00% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $13.57 | +305.31% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.75 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.92 | +50.75% | 1 | May 31, 2022 |
Oruka Therapeutics
Apr 6, 2026
Maintains: Buy
Price Target: $60 → $125
Current: $60.60
Upside: +106.27%
Neumora Therapeutics
Mar 31, 2026
Reiterates: Buy
Price Target: $14
Current: $2.13
Upside: +557.28%
DBV Technologies
Mar 27, 2026
Reiterates: Buy
Price Target: $51
Current: $20.45
Upside: +149.39%
Axsome Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $220 → $245
Current: $168.74
Upside: +45.19%
Cabaletta Bio
Mar 24, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $3.07
Upside: +421.17%
Immunic
Mar 24, 2026
Initiates: Buy
Price Target: $7
Current: $1.19
Upside: +488.24%
InflaRx
Mar 20, 2026
Maintains: Buy
Price Target: $22 → $14
Current: $0.97
Upside: +1,347.48%
Zenas BioPharma
Mar 17, 2026
Maintains: Buy
Price Target: $45 → $55
Current: $22.48
Upside: +144.66%
Adicet Bio
Mar 13, 2026
Maintains: Buy
Price Target: $128 → $100
Current: $6.43
Upside: +1,455.21%
Dianthus Therapeutics
Mar 4, 2026
Maintains: Buy
Price Target: $100 → $200
Current: $86.20
Upside: +132.02%
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $36.76
Upside: +36.02%
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $11.55
Upside: +116.45%
Feb 27, 2026
Maintains: Buy
Price Target: $1,160 → $1,120
Current: $765.43
Upside: +46.32%
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $306.69
Upside: +160.85%
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $760.27
Upside: +28.24%
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $175.61
Upside: +40.08%
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $27.75
Upside: +8.11%
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $24.61
Upside: +78.79%
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $15.92
Upside: +214.07%
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $22.31
Upside: +43.43%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.76
Upside: +298.94%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $62.13
Upside: +60.95%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $116.48
Upside: +28.78%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $17.08
Upside: +17.10%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $26.17
Upside: +186.59%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $130.90
Upside: +33.69%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $5.04
Upside: +415.87%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $14.68
Upside: +97.55%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $5.65
Upside: +165.49%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $25.77
Upside: +74.62%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $22.09
Upside: -9.46%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.90
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $51.20
Upside: +26.95%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $31.35
Upside: +187.08%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.09
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $57.65
Upside: -15.00%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $13.57
Upside: +305.31%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.75
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.92
Upside: +50.75%